MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$621M
Cash and cash
equivalents
$201M
Prepaid expenses and
other current assets
$19M
Receivable from
collaboration partners
$3M
Total current assets
$844M
Other noncurrent
assets
$61M
Long-term marketable
securities
$54M
Property and equipment,
net
$38M
Total assets
$997M
Total liabilities and
stockholders equity
$997M
Total stockholders
equity
$524M
Total current
liabilities
$209M
Other noncurrent
liabilities
$119M
Long-term debt
$100M
Deferred revenue,
noncurrent (36 and 43 to a...
$45M
Accumulated deficit
-$1,613M
Accumulated other
comprehensive loss
-$1M
Common stock and
additional paid-in capital...
$2,138M
Other current
liabilities
$136M
Accounts payable (11 and
24 to a related...
$39M
Deferred revenue (27 and
35 to a related...
$34M
Back
Back
Balance Sheet
source: myfinsight.com
Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences, Inc. (RCUS)